May 16, 2025 · Form 4 insider transaction
Cooke Julie bought 6,468 shares of Neurocrine Biosciences, Inc. at $61.82 per share, a transaction worth $399.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.; 24,994 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power.; Includes an aggregate of 200 shares purchased on February 28, 2025 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.